Demo Sign up Log In

Novo Nordisk A/S Common Stock (NVO)

EBITDA Margin

49.28%

Quarterly · Period ending: Jun 30, 2026

NVO EBITDA Margin

Latest reported49.28%period endingJun 30, 2026

Latest reported49.28%period endingJun 30, 2026

NVO Quarterly EBITDA Margin (100.00% → 49.28%)

Quarterly ebitda margin

High-resolution chart · PNG

NVO ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock EBITDA Margin — Quarterly
Period ending	EBITDA Margin
Jun 30, 2001	100%
Mar 31, 2001	100%
Dec 31, 2000	-665.1085%
Sep 30, 2000	100%
Jun 30, 2000	100%
Mar 31, 2000	100%
Dec 31, 1999	-211.5327%
Sep 30, 1999	100%
Jun 30, 1999	100%
Mar 31, 1999	100%
Dec 31, 1998	-224.9722%
Sep 30, 1998	100%
Jun 30, 1998	100%
Mar 31, 1998	100%
Dec 31, 1997	-212.5258%
Sep 30, 1997	100%
Jun 30, 1997	100%
Mar 31, 1997	100%
Dec 31, 1996	-207.6116%
Sep 30, 1996	100%
Jun 30, 1996	100%
Mar 31, 1996	100%
Dec 31, 1995	-247.1365%
Sep 30, 1995	100%
Jun 30, 1995	100%
Mar 31, 1995	100%
Dec 31, 1994	-228.2886%
Sep 30, 1994	100%
Jun 30, 1994	100%
Mar 31, 1994	100%
Dec 31, 1993	-164.1023%
Sep 30, 1993	100%
Jun 30, 1993	100%
Mar 31, 1993	100%
Dec 31, 1992	-250.4673%
Sep 30, 1992	100%
Jun 30, 1992	100%
Mar 31, 1992	100%
Dec 31, 1991	-186.1515%
Sep 30, 1991	100%
Jun 30, 1991	100%
Mar 31, 1991	100%
Dec 31, 1990	-212.9707%
Sep 30, 1990	100%
Jun 30, 1990	100%
Mar 31, 1990	100%
Dec 31, 1989	-206.2763%
Sep 30, 1989	100%
Jun 30, 1989	100%
Mar 31, 1989	100%
Dec 31, 1988	-186.9171%
Sep 30, 1988	100%
Jun 30, 1988	100%
Mar 31, 1988	100%
Dec 31, 1987	-216.6049%
Sep 30, 1987	100%
Jun 30, 1987	100%
Mar 31, 1987	100%
Dec 31, 1986	-236.9164%
Sep 30, 1986	100%
Jun 30, 1986	100%
Mar 31, 1986	100%
Dec 31, 1985	-228.9088%
Sep 30, 1985	100%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.